Search alternatives:
significant spatial » significant potential (Expand Search), significant negative (Expand Search)
spatial decrease » spatial release (Expand Search), substantial decrease (Expand Search), small decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
lower decrease » linear decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 101 - 120 results of 18,083 for search '(( significant spatial decrease ) OR ( significantly ((lower decrease) OR (larger decrease)) ))', query time: 1.46s Refine Results
  1. 101
    Intraoperative facial and intraoral photographs of the case with mandibular third molar extraction.

    Intraoperative facial and intraoral photographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 102
    Pretreatment facial, intraoral photographs, and radiographs of the case with premolar tooth extraction.

    Pretreatment facial, intraoral photographs, and radiographs of the case with premolar tooth extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 103
    Pretreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction.

    Pretreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 104
    Annual average production of chicks per active nest in the Pristine SW Lake Area (blue triangles) and in Lake Vanajanselkä (red dots connected with a line) during 1972–2017.

    Annual average production of chicks per active nest in the Pristine SW Lake Area (blue triangles) and in Lake Vanajanselkä (red dots connected with a line) during 1972–2017. by Matti Viluksela (321291)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 105
    DataSheet_2_Climate factors drive plant distributions at higher taxonomic scales and larger spatial scales.docx

    DataSheet_2_Climate factors drive plant distributions at higher taxonomic scales and larger spatial scales.docx by Erhan Huang (17772852)

    Published 2024
    “…Edaphic factors congruously decreased their importance on plant distributions as spatial and taxonomic scales increased. …”
    Save to List
    Saved in:
  6. 106
    DataSheet_3_Climate factors drive plant distributions at higher taxonomic scales and larger spatial scales.docx

    DataSheet_3_Climate factors drive plant distributions at higher taxonomic scales and larger spatial scales.docx by Erhan Huang (17772852)

    Published 2024
    “…Edaphic factors congruously decreased their importance on plant distributions as spatial and taxonomic scales increased. …”
    Save to List
    Saved in:
  7. 107
    DataSheet_1_Climate factors drive plant distributions at higher taxonomic scales and larger spatial scales.docx

    DataSheet_1_Climate factors drive plant distributions at higher taxonomic scales and larger spatial scales.docx by Erhan Huang (17772852)

    Published 2024
    “…Edaphic factors congruously decreased their importance on plant distributions as spatial and taxonomic scales increased. …”
    Save to List
    Saved in:
  8. 108
    The results of KEGG enrichment analysis (Annotation: Circles represent each pathway, and the redder the color, the larger the circle, and the more important it is).

    The results of KEGG enrichment analysis (Annotation: Circles represent each pathway, and the redder the color, the larger the circle, and the more important it is). by Lin Zhou (141050)

    Published 2023
    Save to List
    Saved in:
  9. 109
    Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment.

    Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in... by Ranjeeta Adhikari (9905958)

    Published 2023
    Save to List
    Saved in:
  10. 110
    CBP per cumulative year for daratumumab and pembrolizumab per vial.

    CBP per cumulative year for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 111
    S4 Fig -

    S4 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 112
    S1 Fig -

    S1 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 113
    S5 Fig -

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 114
    Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial.

    Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 115
    S3 Fig -

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 116
    S6 Fig -

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 117
    CBP per cumulative indication for daratumumab and pembrolizumab per vial.

    CBP per cumulative indication for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 118
    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation.

    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 119
    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab.

    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 120
    Scenario analysis for daratumumab using a cumulative cost-based price per year per vial.

    Scenario analysis for daratumumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: